ABOUT THE EVENT
Date: Wednesday, September 24, 2025 8am–6:20pm PDT
Event Location: San Francisco , California
Join hubXchange for the Immunotherapies Xchange – San Francisco 2025, an exclusive and highly interactive forum that brings together senior-level executives and scientists from the pharmaceutical and biotech sectors. This event is dedicated to exploring key breakthroughs, challenges, and collaborative solutions in immunotherapy development.
🔹 Key Focus Areas
Immunogenicity
Immune Regulation
Translational Immunology
Immune Biomarkers
Clinical Development
🔹 Why Attend?
✅ Participate in deep-dive roundtable discussions led by industry experts
✅ Gain actionable insights into next-generation immunotherapies
✅ Discover the latest in biomarker strategy, gene circuits, and clinical trial design
✅ Connect in pre-booked 1:1 meetings with peers and potential partners
✅ Learn from spotlight and poster presentations showcasing cutting-edge innovation
Agenda Highlights
Keynote Presentation
Joe Newcome, Senior Director – Minaris Advanced Therapies
Potency Assay Technical Transfer Best Practice
Roundtable Discussions
Bala Medicherla (Astellas Gene Therapies): Modulating immune response to prevent anti-drug antibodies
Greg Timblin (Inapill): Immune metabolic pathways and tolerance
Stefanie Mandl-Cashman (Indapta Therapeutics): Immunotherapy for autoimmune diseases
Léila Delamarre (Genentech): Neoantigen ID and immune monitoring strategies
Anthony Maida (Oncotelic Therapeutics): Clinical trials for rare oncology indications
Olivier Nolan-Stevaux (Gilead): Expanding regulatory T cells for immune tolerance
Dinesh Kumar (Roche): AI-powered multiplex biomarker interpretation pipelines
Venita DeAlmeida (3T Biosciences): Clinical trial design for novel immunotherapeutics
Spotlight Presentations
Jordon Wang (AvantGen): Engineering Unique Properties in Next-Gen Antibody Therapies
Additional speaker TBC
Poster Presentation
1Cell.Ai: Clinical Development topic
